The CSL Ltd (ASX: CSL) share price has seen a very painful last 12 months, as the chart below shows. It's not normal for an ASX 200 healthcare share to fall that much over a relatively short time period.
At the time of writing, the CSL share price has declined by 55% in the past year. Theoretically, if it were to go back to that previous level, it would need to rise around 125%.
Of course, we shouldn't anchor our thoughts to a previous CSL share price. Just because it was at that price before doesn't mean it's going to go back there in the foreseeable future.
But, the CSL share price will move in the coming weeks and months. Let's see what analysts think will happen.
Image source: Getty Images
Expert views on the CSL share price
A number of analysts have had their say on the business over the last three months. Considering the huge decline of the CSL share price, it's not surprising that the business has had analysts lining up to give their view.
In the past three months, there has been 11 ratings on the business. Of those 11 ratings, three ratings were a buy and eight were a hold. So, on average, the investment community are neutral on the the business, though there are a few positive ratings on the ASX healthcare share too.
A price target is also a very interest aspect to look at. Price targets aren't guarantees of future returns. Rather, they're analyst expectations about where share prices will be in 12 months from the time of the investment call.
The average price target on the CSL share price of those 11 ratings is $135.80, which suggests a possible rise of 27% over the next year, at the time of writing.
The most optimistic price target is $234.62, suggesting a huge possible rise of approximately 120% in the year ahead.
But, not every analyst is convinced that the declines have finished. One analyst has a price target $99.79, which implies a possible decline of more than 6% from where it is at the time of writing.
What's the valuation?
According to the earnings projection on CMC Invest, the company's forward price/earnings (P/E) ratio suggests the business is trading at around 12x FY26's estimated earnings.
The forecasts then suggest profit could slightly rise in FY27 and then another 6% in FY28. If earnings can indeed rise, then the CSL share price could be very good value today. But, there are other ASX share names that could deliver stronger earnings growth over the rest of the decade.
